INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Most active filers · 30d

  1. 01Kurtz George0B / 239S · 10 late239 trades$59.22M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08RJRubinstein Julie0B / 37S37 trades$6.25M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Form 4 transactions

19,215 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
22
HD
Hutchinson Michael DChief Operating Officer
TDCTERADATA CORP /DE/
Open-market sale · 10b5-1 plan
SELL$1.44M
48.1K sh
Sep 15, 2026
Page 115 of 481
← PrevNext →
Sep 17, 2026
traded Sep 15, 2026
+2d
SEC Form 4

Evidence

21
CR
Cline Christopher R.CHIEF FINANCIAL OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$1.70M
27.5K sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

21
IJ
Inrig JulaEVP, Head of R&D & CMO
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$1.57M
25.4K sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

21
VS
Verma ShivChief Financial Officer
HOODRobinhood Markets, Inc.
Open-market sale · 10b5-1 plan
SELL$202K
1,800 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

21
IJ
Inrig JulaEVP, Head of R&D & CMO
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$1.08M
17.3K sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

21
CS
Calvin SandraSVP, CHIEF ACCOUNTING OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$266K
4,275 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

21
VS
Verma ShivChief Financial Officer
HOODRobinhood Markets, Inc.
Open-market sale · 10b5-1 plan
SELL$143K
1,289 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

21
VS
Verma ShivChief Financial Officer
HOODRobinhood Markets, Inc.
Open-market sale · 10b5-1 plan
SELL$202K
1,851 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

21
CR
Cline Christopher R.CHIEF FINANCIAL OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$1.30M
20.7K sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

20
JJ
Jergensen JoshuaPresident & COO
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$1.57M
36.5K sh
Sep 16, 2026Sep 17, 2026
traded Sep 16, 2026
+1dSEC Form 4

Evidence

19
BS
Boughton SoleilChief Legal Officer
HIMSHims & Hers Health, Inc.
Open-market sale · 10b5-1 plan
SELL$174K
6,236 sh
Sep 16, 2026Sep 17, 2026
traded Sep 16, 2026
+1dSEC Form 4

Evidence

18
VS
Verma ShivChief Financial Officer
HOODRobinhood Markets, Inc.
Open-market sale · 10b5-1 plan
SELL$32K
300 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

18
VS
Verma ShivChief Financial Officer
HOODRobinhood Markets, Inc.
Open-market sale · 10b5-1 plan
SELL$23K
200 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

17
KJ
Kenneweg JohnSVP, Sales & Product Marketing
MASS908 Devices Inc.
Open-market sale · 10b5-1 plan
SELL$216K
21.4K sh
Sep 16, 2026Sep 17, 2026
traded Sep 16, 2026
+1dSEC Form 4

Evidence

16
MM
Mensinger MikeChief Product Officer
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$58K
2,650 sh
Sep 16, 2026Sep 17, 2026
traded Sep 16, 2026
+1dSEC Form 4

Evidence

16
KL
Kirchhoff Benjamin LouisCHIEF ACCOUNTING OFFICER
IOTSamsara Inc.
Open-market sale · 10b5-1 plan
SELL$92K
2,165 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

16
TS
Turner Michael S.Chief Legal Officer
HAWKHawkEye 360, Inc.
Open-market sale · 10b5-1 plan
SELL$296K
18.3K sh
Sep 16, 2026Sep 17, 2026
traded Sep 16, 2026
+1dSEC Form 4

Evidence

16
SE
Schubach Sarah ElizabethChief Accounting Officer
DBXDROPBOX, INC.
Open-market sale · 10b5-1 plan
SELL$74K
2,025 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

14
RR
Remer Eric RichardDirector
EVCMEverCommerce Inc.
Open-market sale
SELL$2,064
258 sh
Sep 16, 2026Sep 17, 2026
traded Sep 16, 2026
+1dSEC Form 4

Evidence

14
CS
Calvin SandraSVP, CHIEF ACCOUNTING OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$50K
800 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

14
JJ
Jergensen JoshuaPresident & COO
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$153K
3,498 sh
Sep 16, 2026Sep 17, 2026
traded Sep 16, 2026
+1dSEC Form 4

Evidence

14
MA
Misra AmitabhChief Technology Officer
CXMSprinklr, Inc.
Open-market sale · 10b5-1 plan
SELL$229K
40.0K sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

14
OH
Oey Peter HenryChief Financial Officer
GRABGrab Holdings Ltd
Open-market sale · 10b5-1 plan
SELL$145K
50.0K sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

14
GB
Gage BrodieEVP & Chief Product &
CIENCIENA CORP
Open-market sale · 10b5-1 plan
SELL$390K
1,200 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

14
RR
Remer Eric RichardDirector
EVCMEverCommerce Inc.
Open-market sale
SELL$4,266
533 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

14
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Open-market sale
SELL$519
18 sh
Sep 16, 2026Sep 17, 2026
traded Sep 16, 2026
+1dSEC Form 4

Evidence

14
HM
Hanson Scott McLeanDirector, Chief Technology Officer
AMBQAmbiq Micro, Inc.
Open-market sale · 10b5-1 plan
SELL$300K
4,947 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

13
MD
McClymont DonaldDirector, Chief Executive Officer
INDIindie Semiconductor, Inc.
Open-market sale · 10b5-1 plan
SELL$155K
50.0K sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

13
HT
Holme TimothyCHIEF TECHNOLOGY OFFICER
QSQuantumScape Corp
Open-market sale · 10b5-1 plan
SELL$114K
22.5K sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

13
TS
Turner Michael S.Chief Legal Officer
HAWKHawkEye 360, Inc.
Open-market sale · 10b5-1 plan
SELL$134K
8,250 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

13
HT
Holme TimothyCHIEF TECHNOLOGY OFFICER
QSQuantumScape Corp
Open-market sale · 10b5-1 plan
SELL$114K
22.5K sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

11
DD
DiPerna DinoEVP & Chief R&D Officer
CIENCIENA CORP
Open-market sale · 10b5-1 plan
SELL$81K
249 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

11
MA
Misra AmitabhChief Technology Officer
CXMSprinklr, Inc.
Open-market sale · 10b5-1 plan
SELL$164K
29.6K sh
Sep 16, 2026Sep 17, 2026
traded Sep 16, 2026
+1dSEC Form 4

Evidence

11
HM
Hanson Scott McLeanDirector, Chief Technology Officer
AMBQAmbiq Micro, Inc.
Open-market sale · 10b5-1 plan
SELL$116K
1,953 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

11
IJ
Inrig JulaEVP, Head of R&D & CMO
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$102K
1,600 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

11
CS
Calvin SandraSVP, CHIEF ACCOUNTING OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$19K
300 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

11
DD
DiPerna DinoEVP & Chief R&D Officer
CIENCIENA CORP
Open-market sale · 10b5-1 plan
SELL$87K
249 sh
Sep 16, 2026Sep 17, 2026
traded Sep 16, 2026
+1dSEC Form 4

Evidence

11
CR
Cline Christopher R.CHIEF FINANCIAL OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$121K
1,900 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

9
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$371K
2,129 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

9
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$667K
3,901 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence